Moderna Therapeutics Inc v. Arbutus Biopharma Corp

Michael R. Fleming

Steven W. Parmelee

Michael Rosato

Sonja R. Gerrard

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Moderna targets Arbutus's nucleic acid delivery patent, arguing all 22 claims are obvious over the owner's own prior disclosures with overlapping ranges.

Arbutus Biopharma Corp

Moderna Therapeutics Inc

Last Docket Entry Date

Total Docket Entries

IPR2019-00554 | Moderna Therapeutics Inc v. Arbutus Biopharma Corp | Ex Parte

Patent Trial and Appeal Board

Judge	Cases	Inst. Rate	FWD Inv. Rate
Christopher G Paulraj	400+	58%	66%
Jacqueline T Harlow	200+	56%	83%
Timothy G Majors	100+	78%	63%
Timothy G Ma-Jors	1	100%	0%
Tina E Hulse	400+	59%	68%

Name	Ratings
Irell & Manella LLP	L5 A
Michael R. Fleming	L5 A

Name	Ratings
Wilson Sonsini Goodrich & Rosati	L5 A
Steven W. Parmelee	L5 A
Michael Rosato	L5 A
Sonja R. Gerrard	-- -- --